🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12496+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12496 recruiting trials

NARecruitingNCT06445257

A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL

🏥 Huai'an First People's Hospital📍 1 site📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT06421610

OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion.

🏥 Odense University Hospital📍 1 site📅 Started Sep 2023View details ↗
Enrolling by InvitationNCT06212050

Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis

👨‍⚕️ Darren Mylotte, MD, PhD, University of Galway, Galway University Hospital📍 3 sites📅 Started Sep 2023View details ↗
NARecruitingNCT05773729

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia

👨‍⚕️ Chen Jing, M.D., Shanghai Children's Medical Center📍 1 site📅 Started Sep 2023View details ↗
NARecruitingNCT05641116

Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis.

👨‍⚕️ David HUPIN, MD, CHU de Saint Etienne📍 2 sites📅 Started Sep 2023View details ↗
Phase 2RecruitingNCT05917405

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

👨‍⚕️ patrice CHEVALLIER, Pr, Nantes University Hospital📍 23 sites📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT06590025

Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression

👨‍⚕️ Maria J Portella, Dr, Institut de Recerca Sant Pau📍 1 site📅 Started Sep 2023View details ↗
Phase 1, PHASE2RecruitingNCT05797805

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

🏥 Iterion Therapeutics📍 8 sites📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT06045013

Ultrasound-guided Dextrose Injection Versus Dextrose With Methylprednisolone in Carpal Tunnel Syndrome

👨‍⚕️ Igor Begović, MD, General and Veteran Hospital "Croatian Pride" Knin, Croatia📍 1 site📅 Started Sep 2023View details ↗
Phase 2, PHASE3RecruitingNCT05878717

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

🏥 GlaxoSmithKline📍 131 sites📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT05869955

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 54 sites📅 Started Sep 2023View details ↗
NARecruitingNCT06036706

Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:

🏥 Centre Francois Baclesse📍 3 sites📅 Started Sep 2023View details ↗
RecruitingNCT06036056

NMR Based Metabolomics Kinetics in ARDS Patients

👨‍⚕️ Neeraj Sinha, M.Sc., Ph.D., Centre of Biomedical Research📍 1 site📅 Started Sep 2023View details ↗
NARecruitingNCT06029218

Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy

🏥 Centre Antoine Lacassagne📍 1 site📅 Started Sep 2023View details ↗
Phase 1RecruitingNCT06034275

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

👨‍⚕️ Vincerx Study Director, Vincerx Pharma, Inc.📍 5 sites📅 Started Sep 2023View details ↗
NARecruitingNCT06051188

FCV vs PCV in Moderate to Severe ARDS

👨‍⚕️ Rik Endeman, Dr, Erasmus Medical Center📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT06412822

Neutrophil Extracellular Traps (NET's) in Prevalent Kidney Stone

👨‍⚕️ Agnieszka POZDZIK, CHU Brugmann📍 1 site📅 Started Sep 2023View details ↗
RecruitingNCT05897684

Avacostar - (PASS)

🏥 Vifor Fresenius Medical Care Renal Pharma📍 35 sites📅 Started Sep 2023View details ↗
RecruitingNCT05914974

Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies

👨‍⚕️ Dominik Dannehl, Dr., Department of Women's Health Tübingen📍 1 site📅 Started Sep 2023View details ↗
Enrolling by InvitationNCT06634004

Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya

👨‍⚕️ Manus J Donahue, MBA, PhD, Vanderbilt University Medical Center📍 2 sites📅 Started Sep 2023View details ↗
← PreviousPage 377 of 625Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →